全文获取类型
收费全文 | 79164篇 |
免费 | 4877篇 |
国内免费 | 2355篇 |
专业分类
耳鼻咽喉 | 347篇 |
儿科学 | 962篇 |
妇产科学 | 778篇 |
基础医学 | 4700篇 |
口腔科学 | 345篇 |
临床医学 | 11281篇 |
内科学 | 25623篇 |
皮肤病学 | 121篇 |
神经病学 | 3540篇 |
特种医学 | 5790篇 |
外国民族医学 | 2篇 |
外科学 | 8228篇 |
综合类 | 13599篇 |
现状与发展 | 6篇 |
预防医学 | 2117篇 |
眼科学 | 497篇 |
药学 | 5330篇 |
54篇 | |
中国医学 | 2479篇 |
肿瘤学 | 597篇 |
出版年
2024年 | 121篇 |
2023年 | 1106篇 |
2022年 | 2070篇 |
2021年 | 3228篇 |
2020年 | 2892篇 |
2019年 | 2440篇 |
2018年 | 2504篇 |
2017年 | 2265篇 |
2016年 | 2372篇 |
2015年 | 2584篇 |
2014年 | 5453篇 |
2013年 | 5288篇 |
2012年 | 4510篇 |
2011年 | 5002篇 |
2010年 | 4149篇 |
2009年 | 4081篇 |
2008年 | 4233篇 |
2007年 | 4406篇 |
2006年 | 3933篇 |
2005年 | 3299篇 |
2004年 | 2627篇 |
2003年 | 2232篇 |
2002年 | 1874篇 |
2001年 | 1738篇 |
2000年 | 1318篇 |
1999年 | 1146篇 |
1998年 | 1200篇 |
1997年 | 1153篇 |
1996年 | 876篇 |
1995年 | 862篇 |
1994年 | 704篇 |
1993年 | 645篇 |
1992年 | 562篇 |
1991年 | 477篇 |
1990年 | 391篇 |
1989年 | 342篇 |
1988年 | 332篇 |
1987年 | 296篇 |
1986年 | 234篇 |
1985年 | 289篇 |
1984年 | 227篇 |
1983年 | 136篇 |
1982年 | 182篇 |
1981年 | 151篇 |
1980年 | 105篇 |
1979年 | 108篇 |
1978年 | 74篇 |
1977年 | 60篇 |
1976年 | 49篇 |
1975年 | 30篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
31.
32.
Stress Testing Versus CT Angiography in Patients With Diabetes and Suspected Coronary Artery Disease
Abhinav Sharma Adrian Coles Nishant K. Sekaran Neha J. Pagidipati Michael T. Lu Daniel B. Mark Kerry L. Lee Hussein R. Al-Khalidi Udo Hoffmann Pamela S. Douglas 《Journal of the American College of Cardiology》2019,73(8):893-902
Background
The optimal noninvasive test (NIT) for patients with diabetes and stable symptoms of coronary artery disease (CAD) is unknown.Objectives
The purpose of this study was to assess whether a diagnostic strategy based on coronary computed tomographic angiography (CTA) is superior to functional stress testing in reducing adverse cardiovascular (CV) outcomes (CV death or myocardial infarction [MI]) among symptomatic patients with diabetes.Methods
PROMISE (Prospective Multicenter Imaging Study for Evaluation of Chest Pain) was a randomized trial evaluating an initial strategy of CTA versus functional testing in stable outpatients with symptoms suggestive of CAD. The study compared CV outcomes in patients with diabetes (n = 1,908 [21%]) and without diabetes (n = 7,058 [79%]) based on their randomization to CTA or functional testing.Results
Patients with diabetes (vs. without) were similar in age (median 61 years vs. 60 years) and sex (female 54% vs. 52%) but had a greater burden of CV comorbidities. Patients with diabetes who underwent CTA had a lower risk of CV death/MI compared with functional stress testing (CTA: 1.1% [10 of 936] vs. stress testing: 2.6% [25 of 972]; adjusted hazard ratio: 0.38; 95% confidence interval: 0.18 to 0.79; p = 0.01). There was no significant difference in nondiabetic patients (CTA: 1.4% [50 of 3,564] vs. stress testing: 1.3% [45 of 3,494]; adjusted hazard ratio: 1.03; 95% confidence interval: 0.69 to 1.54; p = 0.887; interaction term for diabetes p value = 0.02).Conclusions
In diabetic patients presenting with stable chest pain, a CTA strategy resulted in fewer adverse CV outcomes than a functional testing strategy. CTA may be considered as the initial diagnostic strategy in this subgroup. (PROspective Multicenter Imaging Study for Evaluation of Chest Pain [PROMISE]; NCT01174550) 相似文献33.
34.
35.
36.
37.
目的:探讨美托洛尔(β1受体阻滞剂)用于老年COPD合并冠心病史治疗的临床疗效。方法:选取2018年6月—2019年6月在我院接受治疗的60岁以上(包括60岁)COPD合并冠心病史老年患者,分为对照组与观察组。对照组给予接受布地奈德福莫特罗粉吸入剂治疗,观察组在使用布地奈德福莫特罗粉吸入剂治疗的基础上口服琥珀酸美托洛尔缓释片治疗,观察对比两组治疗效果。结果:观察组临床治疗效果优于对照组,观察组住院时长以及并发症的发生率低于对照组(P<0.05),差异具有统计学意义。结论:老年COPD合并冠心病史接受美托洛尔治疗,可有效缩短住院时长、用药效果明显、有效提升用药安全性,值得临床推广。 相似文献
38.
39.
40.
《Journal of vascular and interventional radiology : JVIR》2020,31(5):760-768.e1
PurposeTo investigate dynamic variables obtained from retrospective computed tomography angiography for ability to predict thoracic endovascular aortic repair (TEVAR) outcomes in patients with complicated type B aortic dissection (cTBAD).Materials and MethodsSeventy-nine patients with cTBAD who received TEVAR from March 2009 to June 2018 were retrospectively enrolled. Relative true lumen area (r-TLA) was computed at the level of tracheal bifurcation every 5% of all R-R intervals. Parameters that reflect the state of intimal motion were evaluated, including difference between maximum and minimum r-TLA (D-TLA) and true lumen collapse. The endpoints comprised early (≤ 30 days) and late (> 30 days) outcomes after intervention.ResultsOverall early mortality rate was 13.9% (11/79), and early adverse events rate was 24.1% (19/79). Patients who received TEVAR within 2 days of symptom onset demonstrated the worst outcomes. A longer time of r-TLA < 25% in 1 cardiac cycle (P = .049) and larger D-TLA (P < .001) were correlated to an increased early death. In addition, D-TLA was an independent predictor of early mortality. Area under the curve of D-TLA was 0.849 (95% confidence interval 0.730–0.967) for predicting early mortality and 0.742 (95% CI 0.611–0.873) for predicting early adverse events. Survival and event-free survival rates during follow-up were decreased in the D-TLA > 21.5% group compared with the D-TLA ≤ 21.5% group (all P < .001).ConclusionsLarger D-TLA is correlated with worse postoperative outcomes and might be a crucial parameter for future risk stratification in patients with cTBAD. 相似文献